InMed Pharmaceuticals (INM) Raw Materials (2022 - 2025)
InMed Pharmaceuticals (INM) reported Raw Materials of $172200.0 for Q3 2025, down 37.26% on a YoY basis from $274445.0 in Q3 2024, and down 33.33% quarter-over-quarter from $258300.0 in Q2 2025.
InMed Pharmaceuticals (INM) Raw Materials (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals has reported Raw Materials for 4 years, with the latest figure at $172200.0 in Q3 2025.
- For the quarter ending Q3 2025, Raw Materials fell 37.26% year-over-year to $172200.0; the trailing twelve-month figure through Sep 2025 stood at $172200.0 (down 37.26% YoY), and the FY2025 full-year result was $258300.0, down 30.69% from the prior year.
- Raw Materials for Q3 2025 stood at $172200.0, down from $258300.0 in the prior quarter.
- The five-year high for Raw Materials was $387071.0 in Q1 2023, with the low at $172200.0 in Q4 2024.
- Historically, Raw Materials has averaged $250874.9 across 4 years, with a median of $233518.5 in 2022.
- The largest YoY upside for Raw Materials was 78.55% in 2024 against a maximum downside of 49.23% in 2024.
- InMed Pharmaceuticals' Raw Materials stood at $208737.0 in 2022, then changed by 0.0% to $208737.0 in 2023, then decreased by 17.5% to $172200.0 in 2024, then changed by 0.0% to $172200.0 in 2025.
- The last three Raw Materials figures came in at $172200.0 (Q3 2025), $258300.0 (Q2 2025), and $258300.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | InMed Pharmaceuticals | 6.00 Mn | 756,271.05 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 172,200.00 |
| Jun 30, 2025 | 258,300.00 |
| Mar 31, 2025 | 258,300.00 |
| Dec 31, 2024 | 172,200.00 |
| Sep 30, 2024 | 274,445.00 |
| Jun 30, 2024 | 372,695.00 |
| Mar 31, 2024 | 196,500.00 |
| Sep 30, 2023 | 208,737.00 |
| Jun 30, 2023 | 208,737.00 |
| Mar 31, 2023 | 387,071.00 |
| Dec 31, 2022 | 208,737.00 |
| Jun 30, 2022 | 292,577.00 |